Follow
Andreas von Ameln-Mayerhofer
Andreas von Ameln-Mayerhofer
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Intranasal delivery of cells to the brain
L Danielyan, R Schäfer, A von Ameln-Mayerhofer, M Buadze, J Geisler, ...
European journal of cell biology 88 (6), 315-324, 2009
3402009
Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease
L Danielyan, R Schäfer, A von Ameln-Mayerhofer, F Bernhard, ...
Rejuvenation research 14 (1), 3-16, 2011
2682011
The neurobehavioral changes induced by bilateral rotenone lesion in medial forebrain bundle of rats are reversed by L-DOPA
M Alam, A Mayerhofer, WJ Schmidt
Behavioural brain research 151 (1-2), 117-124, 2004
852004
Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats
A Mayerhofer, KA Kovar, WJ Schmidt
Neuroscience letters 308 (2), 99-102, 2001
712001
Rewarding effects of the optical isomers of 3, 4-methylenedioxy-methylamphetamine (‘Ecstasy’) and 3, 4-methylenedioxy-ethylamphetamine (‘Eve’) measured by conditioned place …
A Meyer, A Mayerhofer, KA Kovar, WJ Schmidt
Neuroscience letters 330 (3), 280-284, 2002
582002
Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?
WJ Schmidt, A Mayerhofer, A Meyer, KA Kovar
Neuroscience letters 330 (3), 251-254, 2002
512002
Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytes
B Wachter, S Schürger, J Rolinger, A von Ameln-Mayerhofer, D Berg, ...
Cell and tissue research 342, 147-160, 2010
492010
A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewal
TV Wiecki, K Riedinger, A von Ameln-Mayerhofer, WJ Schmidt, MJ Frank
Psychopharmacology 204, 265-277, 2009
482009
Continuous versus pulsatile administration of rotigotine in 6-OHDA-lesioned rats: contralateral rotations and abnormal involuntary movements
WJ Schmidt, H Lebsanft, M Heindl, M Gerlach, E Gruenblatt, P Riederer, ...
Journal of Neural Transmission 115, 1385-1392, 2008
402008
Enantioselective metabolism of the designer drugs 3, 4-methylenedioxymethamphetamine (‘ecstasy’) and 3, 4-methylenedioxyethylamphetamine (‘eve’) isomers in rat brain and blood
A Meyer, A Mayerhofer, KA Kovar, WJ Schmidt
Neuroscience letters 330 (2), 193-197, 2002
292002
Anticataleptic activity of cathinone and MDMA (Ecstasy) upon acute and subchronic administration in rat
MY Banjaw, A Mayerhofer, WJ Schmidt
Synapse 49 (4), 232-238, 2003
272003
Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?
HB Lebsanft, A Mayerhofer, KA Kovar, WJ Schmidt
Journal of neural transmission 110, 707-718, 2003
262003
Short-and long-term unilateral 6-hydroxydopamine lesions in rats show different changes in characteristics of spontaneous firing of substantia nigra pars reticulata neurons
S Seeger-Armbruster, A von Ameln-Mayerhofer
Experimental brain research 224, 15-24, 2013
232013
Chronic co-administration of the cannabinoid receptor agonist WIN55, 212-2 during puberty or adulthood reverses 3, 4 methylenedioxymetamphetamine (MDMA)-induced deficits in …
S Schulz, T Becker, U Nagel, A von Ameln-Mayerhofer, M Koch
Pharmacology Biochemistry and Behavior 106, 91-100, 2013
182013
In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C] methylphenidate and PET
K Fischer, V Sossi, A von Ameln-Mayerhofer, G Reischl, BJ Pichler
Neuroimage 59 (3), 2413-2422, 2012
182012
Imaging DA release in a rat model of L-DOPA-induced dyskinesias: A longitudinal< i> in vivo</i> PET investigation of the antidyskinetic effect of MDMA
NY Lettfuss, K Fischer, V Sossi, BJ Pichler, A von Ameln-Mayerhofer
Neuroimage 63 (1), 423-33, 2012
132012
PRECLINICAL STUDY: Atypical development of behavioural sensitization to 3, 4‐methylenedioxymethamphetamine (MDMA,‘Ecstasy’) in adolescent rats and its expression in adulthood …
N Von Ameln, A Von Ameln‐Mayerhofer
Addiction biology 15 (1), 35-44, 2010
132010
The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization
K Riedinger, A Kulak, WJ Schmidt, A von Ameln-Mayerhofer
Behavioural brain research 218 (1), 194-199, 2011
122011
Is behavioral sensitization to 3, 4-methylenedioxymethamphetamine (MDMA) mediated in part by cholinergic receptors?
NY Lettfuss, S Seeger-Armbruster, A von Ameln-Mayerhofer
Behavioural brain research 244, 116-9, 2013
112013
Modulating endothelial adhesion and migration impacts stem cell therapies efficacy
R Schäfer, M Schwab, G Siegel, A von Ameln-Mayerhofer, M Buadze, ...
EBioMedicine 60, 102987, 2020
92020
The system can't perform the operation now. Try again later.
Articles 1–20